Morgan Stanley’s Intellipharmaceuticals International Inc. IPCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,280
| Closed | -$1K | – | 6835 |
|
|
2018
Q4 | $1K | Hold |
2,280
| – | – | ﹤0.01% | 6561 |
|
|
2018
Q3 | $6K | Buy |
2,280
+150
| +7% | +$395 | ﹤0.01% | 6427 |
|
|
2018
Q2 | $10K | Sell |
2,130
-3,349
| -61% | -$15.7K | ﹤0.01% | 6319 |
|
|
2018
Q1 | $31K | Sell |
5,479
-1,046
| -16% | -$5.92K | ﹤0.01% | 6022 |
|
|
2017
Q4 | $53K | Sell |
6,525
-1,565
| -19% | -$12.7K | ﹤0.01% | 5822 |
|
|
2017
Q3 | $80K | Buy |
8,090
+1,980
| +32% | +$19.6K | ﹤0.01% | 5636 |
|
|
2017
Q2 | $128K | Hold |
6,110
| – | – | ﹤0.01% | 5540 |
|
|
2017
Q1 | $153K | Sell |
6,110
-10
| -0.2% | -$250 | ﹤0.01% | 5436 |
|
|
2016
Q4 | $174K | Sell |
6,120
-70
| -1% | -$1.99K | ﹤0.01% | 5402 |
|
|
2016
Q3 | $130K | Buy |
6,190
+250
| +4% | +$5.25K | ﹤0.01% | 5206 |
|
|
2016
Q2 | $92K | Buy |
5,940
+656
| +12% | +$10.2K | ﹤0.01% | 5278 |
|
|
2016
Q1 | $109K | Sell |
5,284
-280
| -5% | -$5.78K | ﹤0.01% | 5280 |
|
|
2015
Q4 | $112K | Sell |
5,564
-406
| -7% | -$8.17K | ﹤0.01% | 5348 |
|
|
2015
Q3 | $109K | Sell |
5,970
-404
| -6% | -$7.38K | ﹤0.01% | 5384 |
|
|
2015
Q2 | $187K | Buy |
6,374
+260
| +4% | +$7.63K | ﹤0.01% | 5274 |
|
|
2015
Q1 | $170K | Hold |
6,114
| – | – | ﹤0.01% | 5283 |
|
|
2014
Q4 | $138K | Sell |
6,114
-3,550
| -37% | -$80.1K | ﹤0.01% | 5412 |
|
|
2014
Q3 | $291K | Sell |
9,664
-14,903
| -61% | -$449K | ﹤0.01% | 4925 |
|
|
2014
Q2 | $936K | Buy |
24,567
+10,392
| +73% | +$396K | ﹤0.01% | 4104 |
|
|
2014
Q1 | $624K | Buy |
14,175
+8,286
| +141% | +$365K | ﹤0.01% | 4401 |
|
|
2013
Q4 | $219K | Buy |
+5,889
| New | +$219K | ﹤0.01% | 4984 |
|